Australia can't claim a single world-class pharmaceutical company - a sad indictment of our level of support for medical innovation, argues UNSW Professor Phil Hogg.
Australia could be a world leader in medical innovation but risk aversion and parochialism are holding the industry back, a leading venture capitalist will argue at a public debate at the UNSW next week.
New developments in research into depression and other mental disorders will be discussed at a major symposium at UNSW next week.
Driving 'stoned' can increase the chance of having an accident by up to 300 percent, according to UNSW's National Cannabis Prevention and Information Centre.
UNSW and The Black Dog Institute are seeking participants for a trial of a new, non-invasive form of brain stimulation therapy for depression, known as Direct Current Stimulation (DCS).
UNSW researchers have given heart attack sufferers new hope with the development of a drug that dramatically reduces damage to the heart.
The work of some of Australia's most acclaimed Indigenous artists is on show at Shalom College this week to fund scholarships for UNSW Indigenous medical students.
Three UNSW research teams have received fast-tracked funding to study the evolving threat of swine flu.
Five-hundred Australians are being sought by UNSW and the Black Dog Institute for a study to pinpoint the risk factors for developing bipolar disorder.
Researchers from UNSW and the Children's Cancer Institute Australia have developed a new approach to the treatment of acute myeloid leukaemia (AML), one of the most aggressive forms of the disease.